the ESOP warrants because there had been changes to the Board of Directors. 5. That the TRIS Rating for the year 2018, be acknowledged. TRIS Rating affirms the company rating of the Company at “A-”. At
Injection Not exceed USD 55,000,000 (Approximately Baht 1,685 million) Purpose of investment For the purpose of organization restructuring for the Company’s Brazil subsidiary as well as to be more flexible
resources especially the back-office functions as well as the management team to streamline our service operations and to save cost. Financial Position As of the year ended 2019 and for the period as of June
The Company 82.77 176.41 -53% * Non-cash items included depreciation as well as accounting adjustment Page 2 of 4 Revenue from hospital operations of the first quarter of 2020 (“1Q’20”) was THB 447.23
) (40.61) (8.60) 13.52/1 (33.29) Note/1 Net loss decreased compared to the year 2018 by Baht 13.52 million or equivalent to 33.29%. For the year 2019, the Company has total revenues at Baht 548.29 million
2020, ended June 30, 2020 The operating results of the Company and its subsidiaries for the second quarter of 2020, ended June 30, 2020 was described in the financial statement showing net loss at the
a letter from ACO I to confirm the amount of transferred debt as at January 31, 2017, of USD 91,589,712, or equivalent to THB 3,160,689,724.68 (divided into principal of USD 58,392,108 or equivalent
continuously improved, mainly due to a growing number of exporting goods by 10.9 percent. This expansion was said to be at the highest rate in 4 years. The private consumption has also increased with declining
gross profit margin at 46.0%. Net profit for the six-month period ended 30 June 2019 showed at Baht 119.47 million, increased from the same period of last year by Baht 24.33 million or 25.6%. Earnings per
and subsidiaries had total revenue for Q3/2018 and Q3/2017 at Baht 163.93 million, and Baht 224.78 million respectively. The decrease of Baht 60.85 million is equivalent to 27.07%, compared to Q3/2017